TCTR20210929008
Recruiting
N/A
A Comparative clinical outcome study of Children with Severe Pneumonia at KCMH and ASIAN PICU(PACCMAN)
/A0 sites100 target enrollmentSeptember 29, 2021
Conditionssevere pneumonia in children
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- severe pneumonia in children
- Sponsor
- /A
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Children \< 18 years old.
- •2\.Admitted to one of the PICUs in the collaborative network.
- •3\.Evidence of acute infection as defined as reported fever, documented fever or hypothermia, leukocytosis or leucopenia.
- •4\.Evidence of acute respiratory illness as defined as new cough or sputum production, chest pain, dyspnea, tachypnea, abnormal respiratory examination findings or respiratory failure.
- •5\.Radiological evidence of pneumonia within 72 hours before or after admission.
Exclusion Criteria
- •1\.Children with active do\-not\-resuscitate (DNR) orders
- •2\.Children that have already been enrolled in this study within the previous 28 days
- •3\.Have an alternative diagnosis of a respiratory disorder
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Kerosene poisoning in ChildreHealth Condition 1: null- Children below 5 years admitted with Kerosene consumptionCTRI/2014/08/004813Father Muller Medical College50
Not Yet Recruiting
N/A
A retrospective study of the outcome of children with neuroblastoma after relapse. the Japan neuroblastoma study group.neuroblastomaJPRN-UMIN000004198Japan Neuroblastoma study group125
Active, Not Recruiting
Phase 1
Follow-Up study in Previously Treated Children to investigate a new FVIII concentrateEUCTR2011-001785-17-PLOctapharma AG50
Active, Not Recruiting
Phase 1
Follow-Up study in Previously Treated Children to investigate a new FVIII concentrateSevere Haemophilia AMedDRA version: 14.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2011-001785-17-CZOctapharma AG60
Active, Not Recruiting
Phase 1
Follow-Up study in Previously Treated Children to investigate a new FVIII concentrateSevere Haemophilia AMedDRA version: 14.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2011-001785-17-FROctapharma AG60